VERHEIJ SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Here we report on an 18-years-old female patient with 13.1 kb deletion of 8q24.3 fusing the 5'-portion of SCRIB with the 3'-portion of PUF60 and presenting with borderline intellectual disability, eye coloboma, short stature, scoliosis, heart defects and interestingly postnatal megalencephaly, in contrast to microcephaly, which is usually associated with 8q24.3 deletion (Verheij syndrome).
|
30472487 |
2019 |
VERHEIJ SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Role of PUF60 gene in Verheij syndrome: a case report of the first Chinese Han patient with a de novo pathogenic variant and review of the literature.
|
30352594 |
2018 |
VERHEIJ SYNDROME
|
0.740 |
GeneticVariation
|
disease |
BEFREE |
Among these, a two base pair deletion was identified in the PUF60 gene, which is one of three genes in the critical region of the 8q24.3 microdeletion syndrome (Verheij syndrome).
|
28990276 |
2018 |
VERHEIJ SYNDROME
|
0.740 |
Biomarker
|
disease |
BEFREE |
Recently, PUF60 (Poly-U Binding Splicing Factor 60 kDa), which encodes a component of the spliceosome, has been discussed as the best candidate gene for the Verheij syndrome phenotype, regarding the cardiac and short stature phenotype.
|
27804958 |
2016 |
VERHEIJ SYNDROME
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.
|
24140112 |
2013 |
VERHEIJ SYNDROME
|
0.740 |
GeneticVariation
|
disease |
UNIPROT |
SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.
|
24140112 |
2013 |
VERHEIJ SYNDROME
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SCRIB and PUF60 are primary drivers of the multisystemic phenotypes of the 8q24.3 copy-number variant.
|
24140112 |
2013 |
VERHEIJ SYNDROME
|
0.740 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
An 8.35 Mb overlapping interstitial deletion of 8q24 in two patients with coloboma, congenital heart defect, limb abnormalities, psychomotor retardation and convulsions.
|
19464398 |
2009 |
VERHEIJ SYNDROME
|
0.740 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
VERHEIJ SYNDROME
|
0.740 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
VERHEIJ SYNDROME
|
0.740 |
Biomarker
|
disease |
CTD_human |
|
|
|
Intellectual Disability
|
0.330 |
Biomarker
|
group |
BEFREE |
Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.
|
28990276 |
2018 |
Intellectual Disability
|
0.330 |
Biomarker
|
group |
BEFREE |
PUF60 deficiency (PD) causes a developmental delay coupled with intellectual disability and spinal, cardiac, ocular and renal defects, but PD pathogenesis is not understood.
|
29788428 |
2018 |
Intellectual Disability
|
0.330 |
GeneticVariation
|
group |
BEFREE |
Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.
|
27804958 |
2016 |
Intellectual Disability
|
0.330 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Consistent with these findings, we identified an individual with microcephaly, short stature, intellectual disability, and heart defects with a de novo c.505C>T variant leading to a p.His169Tyr change in PUF60.
|
24140112 |
2013 |
Mesothelioma
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
|
21435101 |
2011 |
Necrosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
|
21435101 |
2011 |
Neoplasms, Experimental
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
|
21435101 |
2011 |
Developmental delay (disorder)
|
0.130 |
Biomarker
|
phenotype |
BEFREE |
PUF60 deficiency (PD) causes a developmental delay coupled with intellectual disability and spinal, cardiac, ocular and renal defects, but PD pathogenesis is not understood.
|
29788428 |
2018 |
Global developmental delay
|
0.130 |
Biomarker
|
disease |
BEFREE |
PUF60 deficiency (PD) causes a developmental delay coupled with intellectual disability and spinal, cardiac, ocular and renal defects, but PD pathogenesis is not understood.
|
29788428 |
2018 |
Developmental delay (disorder)
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
In 2013, patients with microdeletions of chromosome 8q24.3 including PUF60 were found to have developmental delay, microcephaly, craniofacial, renal and cardiac defects.
|
28327570 |
2017 |
Global developmental delay
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
In 2013, patients with microdeletions of chromosome 8q24.3 including PUF60 were found to have developmental delay, microcephaly, craniofacial, renal and cardiac defects.
|
28327570 |
2017 |
Developmental delay (disorder)
|
0.130 |
GeneticVariation
|
phenotype |
BEFREE |
All six patients with a PUF60 variant (the five patients of the present study and the unique reported patient) have the same core facial gestalt as 8q24.3 microdeletions patients, associated with DD.
|
27804958 |
2016 |
Global developmental delay
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
All six patients with a PUF60 variant (the five patients of the present study and the unique reported patient) have the same core facial gestalt as 8q24.3 microdeletions patients, associated with DD.
|
27804958 |
2016 |
Developmental delay (disorder)
|
0.130 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|